Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Are Concerns Over Avacopan Efficacy Overblown?

(MedPage Today) -- Avacopan (Tavneos), the complement pathway inhibitor for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), appeared strongly effective in an Italian registry study -- a step, maybe, toward setting to rest...

Are Concerns Over Avacopan Efficacy Overblown?

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Monday 12 October →